Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
dexamethasone (1 trial)
doxorubicin (Doxil) (1 trial)
imatinib (gleevec) (1 trial)
inotuzumab ozogamicin (besponsa) (1 trial)
vincristine (oncovin) (1 trial)
Leukemia (Phase 3)
Leukemia, Lymphoid (Phase 3)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 3)
Trials (1 total)
Trial APIs (5 total)